Humana plans $2.8 billion primary care deal with BlackRock, expanding CenterWell clinic ownership

Humana said it is entering a large primary care venture with investment manager BlackRock, a deal Humana described as worth $2.8 billion. The insurer’s announcement centers on its CenterWell senior healthcare division, through which it owns primary care clinics focused on older adults.

Under the agreement, BlackRock will acquire a majority stake in nearly 150 senior primary care clinics. The announcement does not describe the exact structure beyond the ownership stake, but it frames the transaction as a way to pair Humana’s care delivery platform with BlackRock’s capital and investment capabilities.

The deal highlights how asset managers are increasingly active in healthcare operating models, not just public equities or corporate credit. For insurers, bringing in an outside investor can shift capital requirements and potentially change the balance between owning clinics directly versus sharing ownership and long-term economics.

Humana’s CenterWell has positioned its in-house care delivery footprint as part of its broader approach to serving Medicare-age and senior patients. In that context, clinic ownership and operations can become a strategic asset, since primary care availability is closely tied to patient management, care coordination, and downstream utilization across the healthcare system.

While the announcement specifies the overall value ($2.8 billion) and the scale of the clinic portfolio (nearly 150 clinics), it does not provide details in the publicly described post about clinic locations, expected integration steps, or the timetable for regulatory approvals and closing.

It also does not disclose whether the transaction changes governance, clinical operations, staffing models, or reimbursement arrangements at the clinic level. Those items can materially affect execution risk, and the announcement, as presented, leaves investors with limited visibility into how the venture will function day to day.

BlackRock, which manages funds and invests in a wide range of assets, is effectively stepping into a healthcare delivery segment where the economics are driven by patient volumes, payer contracting, and care outcomes. The company’s involvement, as described, indicates continued interest in healthcare infrastructure that can generate cash flows over time.

What to watch next is what Humana and BlackRock disclose as the deal progresses, including the final stake percentage, any financial terms beyond the headline value, the closing timeline, and how responsibilities will be divided between the parties for clinic operations and oversight. Any regulatory or antitrust review, as well as disclosures about management and incentives, will be key to assessing how the venture could scale.